[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362769-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362769-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unveiling-the-role-of-angpt2-in-esophageal-cancer-a-prognostic-factor-and-potential-oncogene","Unveiling the role of ANGPT2 in esophageal cancer - A prognostic factor and potential oncogene","","Esophageal cancer (ESCA) shows high incidence and mortality, yet the functional mechanisms of angiopoietin‑2 (ANGPT2) remain insufficiently defined. Using clinical samples and public genomic resources, ANGPT2 expression was assessed for clinical relevance and prognostic value, identifying it as an independent prognostic factor and potential oncogene. Aberrant ANGPT2 levels were linked to ESCA migration and invasion in vitro. Further correlation and expression analyses uncovered upstream long‑chain non‑coding RNAs and microRNAs regulating ANGPT2, connecting ANGPT2 with tumor immunity, microenvironment infiltration, immune markers, and immune checkpoints.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unveiling-the-role-of-angpt2-in-esophageal-cancer-a-prognostic-factor-and-potential-oncogene/362769/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unveiling-the-role-of-angpt2-in-esophageal-cancer-a-prognostic-factor-and-potential-oncogene/362769.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ANGPT2’s proposed role in esophageal cancer?","Question",{"text":63,"@type":64},"The study evaluates ANGPT2 as an independent prognostic factor and a potential oncogene in ESCA, linking its abnormal expression to tumor behavior and immune features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was ANGPT2 expression associated with prognosis and clinical relevance?",{"text":68,"@type":64},"Clinical samples and multiple public databases were used to analyze ANGPT2 expression, showing prognostic and clinical associations in ESCA.",{"name":70,"@type":61,"acceptedAnswer":71},"What immune-related mechanisms connect ANGPT2 to tumor microenvironment changes?",{"text":72,"@type":64},"Gene set enrichment analysis indicates a connection between ANGPT2 and the immune system, including correlation with immune cell infiltration, immune marker expression, and immune checkpoint expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362769,1790256589,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ONCOLOGY REPORTS 55: 93, 2026  \nUnveiling the role ofANGPT2 in esophageal cancer: A prognostic factor and potential oncogene  \nZHIGANG ZHAI 1* , ZHENYU XUE2* , YUAN FANG3* , YIXU FAN3 , SHIJIAO LI3 , YUNPENG YU 1 , CHUANSHENG CHEN3 , KAIJUN ZHANG3 , DEYU CHEN2 , XIANG TANG3 and RUI LING 1  \n1Thoracic Oncology Department, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China; 2Head and Neck Oncology Department, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China; 3Abdominal Oncology Department, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China  \nReceived September 11, 2025; Accepted February 26, 2026  \nDOI: 10. 3892/or.2026.9098  \nAbstract. Esophageal cancer (ESCA) is defined by high incidence and mortality rates. Emerging evidence implicatesangiopoietin‑2 (ANGPT2) as a key mediator in human carci‑ nogenesis; however, its precise functional role and underlying mechanisms in ESCA remain incompletely elucidated. Clinical samples and The Cancer Genome Atlas, genotype‑tissue expression and Gene Expression Omnibus databases were first used to analyze ANGPT2 expression, clinical relevance and prognostic value, demonstrating it as an independent prog‑ nostic factor and potential oncogene in ESCA. In addition, abnormal ANGPT2 expression affected ESCA migration and invasion in vitro. Subsequently, through correlation, expression and prognostic analyses, the upstream long‑chain non‑coding RNAs and microRNAs that regulate ANGPT2 were identified.  \nCorrespondence to: Dr Xiang Tang, Abdominal Oncology Department, Affiliated Hospital of Jiangsu University, 438 Jiefang Road, Zhenjiang, Jiangsu 212001, P.R. China  \nE‑[mail: ujstx1994@163.com](mail: ujstx1994@163.com)  \nDr Rui Ling, Thoracic Oncology Department, The Affiliated Hospital of Jiangsu University, 438 Jiefang Road, Zhenjiang, Jiangsu 212001, P.R. China  \nE‑mail: [lingruiray@163.com](lingruiray@163.com)  \n*Contributed equally  \nAbbreviations: BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; PRAD, pancreatic adenocarcinoma; READ, rectum adenocarcinoma; STAD, stomach adenocarcinoma; THCA, thyroid carcinoma; UCEC, uterine corpus endometrial carcinoma  \nKey words: angiopoietin‑2, esophageal cancer, prognosis, biomarker, immunity  \nIn conclusion, gene set enrichment analysis revealed a connec‑ tion between ANGPT2 and the immune system, with ANGPT2 level showing a strong positive correlation with tumor microen‑ vironment cell infiltration, immune cell markers, and immune checkpoint expression. Furthermore, ANGPT2 expression was significantly associated with sensitivity to chemotherapeutic drugs. To summarize, overexpression of ANGPT2 in ESCAis associated with an unfavorable prognosis and compromised tumor immunity.  \nIntroduction  \nEsophageal cancer (ESCA) is the 6th leading cause of cancer‑related mortality globally. Tens of thousands of individuals are diagnosed with ESCA each year (1) . Despite significant progress in surgical, chemotherapy and radiation therapies for ESCA, the fatality rate remains elevated, with a five‑year survival rate not exceeding 20%(2) . An accu‑ mulating body of studies shows that numerous factors, such as smoking (3), alcohol consumption (4), gastroesophageal reflux disease (5), the immune system (6) and obesity (7), are related to the initiation and progression of ESCA. Accordingly, identifying promising biomarkers for ESCA diagnosis and prognosis is urgent.  \nAngiopoietins (ANGPT) represent a family of secreted factors that include ANGPT1/2/3/4 (in humans) (8‑10) . ANGPT2 is an antagonistic ligand that maintains th","cbCaiq1lRff92L5C","https://ap.wps.com/l/cbCaiq1lRff92L5C","pdf",9483774,18,"English","# Introduction\n## ANGPT2 background in cancer and immunity\n# Abstract findings\n## Clinical relevance and prognostic value\n## Functional effects on migration and invasion\n## Upstream lncRNAs/miRNAs regulation\n## Immune connection and chemotherapy sensitivity","[{\"question\":\"What is ANGPT2’s proposed role in esophageal cancer?\",\"answer\":\"The study evaluates ANGPT2 as an independent prognostic factor and a potential oncogene in ESCA, linking its abnormal expression to tumor behavior and immune features.\"},{\"question\":\"How was ANGPT2 expression associated with prognosis and clinical relevance?\",\"answer\":\"Clinical samples and multiple public databases were used to analyze ANGPT2 expression, showing prognostic and clinical associations in ESCA.\"},{\"question\":\"What immune-related mechanisms connect ANGPT2 to tumor microenvironment changes?\",\"answer\":\"Gene set enrichment analysis indicates a connection between ANGPT2 and the immune system, including correlation with immune cell infiltration, immune marker expression, and immune checkpoint expression.\"}]","Unveiling the role of ANGPT2 in esophageal cancer - A prognostic factor and potential oncogene | PDF",1790149054,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/714243859b76c19cc8a63b024482c546.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bebd4eb96becaf46b0d15eb4f9e6ec03.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b672dcd761a019718bd0adb8459d15dc.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/198b188aa4415387854fdbe0e5d209ed.webp",980,1353]